| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Jasper Therapeutics, Inc. | Director | Stock Option (right to buy) | 7,500 | 03 Jul 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| JSPR | Jasper Therapeutics, Inc. | 03 Jul 2025 | 1 | $0 | 4 | Director | 03 Jul 2025, 16:22 |
| JSPR | Jasper Therapeutics, Inc. | 06 Jun 2024 | 1 | $0 | 4 | Director | 10 Jun 2024, 18:24 |
| JSPR | Jasper Therapeutics, Inc. | 07 Jun 2023 | 1 | $0 | 4 | Director | 08 Jun 2023, 18:44 |
| JSPR | Jasper Therapeutics, Inc. | 16 Feb 2023 | 0 | $0 | 3/A | Director | 27 Feb 2023, 19:35 |
| JSPR | Jasper Therapeutics, Inc. | 16 Feb 2023 | 1 | $0 | 4 | Director | 17 Feb 2023, 07:30 |